• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Org 9426(罗库溴铵)在日本患者中的神经肌肉阻滞作用、药代动力学及安全性]

[Neuromuscular blocking effects, pharmacokinetics and safety of Org 9426 (rocuronium bromide) in Japanese patients].

作者信息

Suzuki Takahiro, Saeki Shigeru, Takeda Junzo, Ozaki Makoto, Iwao Yasuhide

机构信息

Department of Anesthesiology, Surugadai Nihon University Hospital, Tokyo 101-8309.

出版信息

Masui. 2006 Apr;55(4):419-27.

PMID:16634542
Abstract

BACKGROUND

The purpose of this study was to examine pharmacodynamics, pharmacokinetics and safety of Org 9426 (rocuronium bromide) in Japanese patients.

METHODS

Seventy-eight patients anesthetized with thiopental, droperidol, fentanyl and nitrous oxide, were randomized to receive either a single dose of Org 9426 0.3 mg x kg(-1), 0.6 mg x kg(-1) or 0.9 mg x kg(-1). Contraction of the adductor pollicis to the ulnar nerve stimulation (0.1 Hz) was measured by acceleromyography. Blood was sampled over 6 hr and pharmacokinetic variables were calculated by plasma concentrations of Org 9426.

RESULTS

Onset times for patients receiving 0.3 mg x kg(-1), 0.6 mg x kg(-1) or 0.9 mg x kg(-1) were 271.5 s, 140.0s and 125.4s, respectively. There was a dose-dependent increase in clinical durations until 25% recovery of twitch height (17.4 min in 0.3 mg x kg(-1) group, 37.2 min in 0.6 mg x kg(-1) and 60.4 min in 0.9 mg x kg(-1) group). Pharmacokinetic study revealed that elimination half life, steady state volume of distribution and plasma clearance of Org 9426 were 48-76 min, 146-181 ml x kg(-1), and 3.8-4.5 ml x min(-1) x kg(-1), respectively. No adverse effects were found except a case of local erythema on a forearm.

CONCLUSIONS

The efficacy of neuromuscular block, stable pharmacokinetic behavior and excellent safety of Org 9426 were also confirmed in Japanese surgical patients.

摘要

背景

本研究旨在考察Org 9426(罗库溴铵)在日本患者中的药效学、药代动力学及安全性。

方法

78例接受硫喷妥钠、氟哌利多、芬太尼和氧化亚氮麻醉的患者,随机接受单次剂量的Org 9426,剂量分别为0.3 mg·kg⁻¹、0.6 mg·kg⁻¹或0.9 mg·kg⁻¹。通过加速度描记法测量尺神经刺激(0.1 Hz)引起的拇内收肌收缩。在6小时内采集血样,并根据Org 9426的血浆浓度计算药代动力学变量。

结果

接受0.3 mg·kg⁻¹、0.6 mg·kg⁻¹或0.9 mg·kg⁻¹的患者起效时间分别为271.5秒、140.0秒和125.4秒。临床作用持续时间呈剂量依赖性增加,直至颤搐高度恢复25%(0.3 mg·kg⁻¹组为17.4分钟,0.6 mg·kg⁻¹组为37.2分钟,0.9 mg·kg⁻¹组为60.4分钟)。药代动力学研究表明,Org 9426的消除半衰期、稳态分布容积和血浆清除率分别为48 - 76分钟、146 - 181 ml·kg⁻¹和3.8 - 4.5 ml·min⁻¹·kg⁻¹。除1例前臂局部红斑外,未发现不良反应。

结论

在日本外科手术患者中也证实了Org 9426神经肌肉阻滞的有效性、稳定的药代动力学行为及出色的安全性。

相似文献

1
[Neuromuscular blocking effects, pharmacokinetics and safety of Org 9426 (rocuronium bromide) in Japanese patients].[Org 9426(罗库溴铵)在日本患者中的神经肌肉阻滞作用、药代动力学及安全性]
Masui. 2006 Apr;55(4):419-27.
2
The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.新型非去极化神经肌肉阻滞剂Org 9426在接受氧化亚氮、氟烷和芬太尼麻醉的患者中的药效学和药代动力学。
Can J Anaesth. 1991 May;38(4 Pt 1):430-5. doi: 10.1007/BF03007578.
3
Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.氟烷麻醉期间单次注射和持续输注罗库溴铵后的药代动力学
Br J Anaesth. 1996 Jan;76(1):29-33. doi: 10.1093/bja/76.1.29.
4
The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.罗库溴铵在肝硬化患者中的药代动力学和药效学。
Br J Clin Pharmacol. 1997 Aug;44(2):139-44. doi: 10.1046/j.1365-2125.1997.00653.x.
5
[Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients].
Masui. 2006 Sep;55(9):1140-8.
6
Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.在丙泊酚或异氟烷稳定麻醉下罗库溴铵的药代动力学-药效学关系
Can J Anaesth. 2002 Apr;49(4):353-60. doi: 10.1007/BF03017322.
7
[Randomized, multicenter study of interaction between Org 9426 (rocuronium bromide) and anesthetic agents in Japanese population].[日本人群中Org 9426(罗库溴铵)与麻醉剂相互作用的随机多中心研究]
Masui. 2006 Jul;55(7):873-9.
8
Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics.罗库溴铵(Org 9426)的临床药理学:作用时间过程、剂量需求、可逆性及药代动力学研究
J Clin Anesth. 1994 Jul-Aug;6(4):288-96. doi: 10.1016/0952-8180(94)90075-2.
9
Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.在一项随机多中心研究中,舒更葡糖钠对罗库溴铵所致深度神经肌肉阻滞的早期逆转作用:疗效、安全性及药代动力学
Anesthesiology. 2007 May;106(5):935-43. doi: 10.1097/01.anes.0000265152.78943.74.
10
Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients.罗库溴铵对麻醉患者膈肌和拇内收肌的神经肌肉作用。
Anesthesiology. 1994 Sep;81(3):585-90. doi: 10.1097/00000542-199409000-00010.

引用本文的文献

1
Anesthetic management of a patient with subclinical myasthenia gravis who underwent a thymectomy: a case report.1例接受胸腺切除术的亚临床型重症肌无力患者的麻醉管理:病例报告
JA Clin Rep. 2022 Jul 15;8(1):49. doi: 10.1186/s40981-022-00541-4.
2
Rocuronium Has a Suppressive Effect on Platelet Function via the P2Y12 Receptor Pathway In Vitro That Is Not Reversed by Sugammadex.罗库溴铵通过体外 P2Y12 受体途径抑制血小板功能,而 sugammadex 不能逆转这种抑制作用。
Int J Mol Sci. 2020 Sep 3;21(17):6399. doi: 10.3390/ijms21176399.